Pyxis Oncology, Inc. (PYXS)
NASDAQ · Healthcare
Pyxis Oncology, Inc. Operating Income 2024–2025
Pyxis Oncology, Inc. annual/quarterly operating income history and growth rate from 2024 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Pyxis Oncology, Inc. operating income for the quarter ending June 30, 2025 was -19.8 M.
- Pyxis Oncology, Inc. annual operating income for 2025 was -84.4 M, a 5.63% decrease from 2024.
- Pyxis Oncology, Inc. annual operating income for 2024 was -89.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pyxis Oncology, Inc. Operating Income — FAQ
Pyxis Oncology, Inc. (PYXS) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Pyxis Oncology, Inc.'s operating income?
Pyxis Oncology, Inc. (PYXS) reported operating income of -$84M for fiscal 2025.
Where can I see PYXS's operating income history?
The chart and table above show Pyxis Oncology, Inc.'s operating income by year and by quarter, including the growth rate.